Skip to main content
KalVista Pharmaceuticals, Inc. logo

KalVista Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · KALV ISIN · US4834971032 LEI · 529900Q7IDA3WUGRZA51 US Manufacturing
Filings indexed 808 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country US United States of America
Listing US KALV

About KalVista Pharmaceuticals, Inc.

https://www.kalvista.com/

KalVista Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes oral therapies for rare diseases. The company specializes in small molecule protease inhibitors, with a primary focus on hereditary angioedema (HAE). Leveraging deep expertise in the plasma kallikrein-kinin system, KalVista has developed the first and only oral, on-demand treatment for HAE attacks. The company's mission is to elevate the standard of care and address significant unmet medical needs for patients by providing innovative, orally-delivered medicines.

Recent filings

Filing Released Lang Actions
8-K - KalVista Pharmaceuticals, Inc. (0001348911) (Filer)
Regulatory Filings
2026-04-29 English
4 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
Director's Dealing
2026-03-27 English
8-K - KalVista Pharmaceuticals, Inc. (0001348911) (Filer)
Regulatory Filings
2026-03-25 English
4 - KALVISTA PHARMACEUTICALS, INC. (0001348911) (Filer)
Director's Dealing
2026-02-25 English
4 - KALVISTA PHARMACEUTICALS, INC. (0001348911) (Filer)
Director's Dealing
2026-02-25 English
4 - KALVISTA PHARMACEUTICALS, INC. (0001348911) (Filer)
Director's Dealing
2026-02-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.